Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A mouse
tyrosinase
cDNA has been combined with different promoters and inserted into several replication-competent avian leukosis proviruses and the viruses were transferred into cultured albino chick cells by viral infection. Expression of the
tyrosinase
gene depended on one of four promoter sequences: the resident constitutive promoter (
Rous sarcoma
virus long-terminal repeat; RSV-LTR), 471 bp from the mouse
tyrosinase
gene-associated promoter, 519 bp from the Japanese quail
tyrosinase
gene associated promoter, or 369 bp from the quail
tyrosinase
promoter. The infected cells expressed
tyrosinase
and produced pigment which could be seen with the light microscope. Immunofluorescence microscopy, using an anti mouse
tyrosinase
T1-specific antibody, also showed the presence of mouse
tyrosinase
. When infected with the same viral titer, gene expression was highest with the constitutive LTR promoter. The quail
tyrosinase
promoter, while less efficient than the LTR, was more efficient than the other
tyrosinase
promoter. Fibroblasts and hepatocytes infected with the construct carrying the constitutive promoter or the truncated quail promoter expressed
tyrosinase
. The mouse and quail promoters appeared to show tissue-specific expression since fibroblasts and hepatocytes infected with viruses carrying these promoters did not express mouse
tyrosinase
. Toxicity is associated with constitutive expression of
tyrosinase
in nonmelanocytes. Therefore the viruses that carry the tissue specific promoters should be useful for in vivo studies.
...
PMID:Tissue-specific expression of mouse tyrosinase gene in cultured chicken cells. 808 18
Tyrosinase, the key gene in melanin pigment synthesis, is tissue-specifically expressed in melanocytic cells. Expression of this gene is regulated by various hormones, carcinogens, and environmental factors. The molecular basis underlying
tyrosinase
gene regulation is still not clear. In this report, we present the effects of tumor suppressor p53 protein in
tyrosinase
gene expression and melanin synthesis in human melanoma. After stable transfection of wild type p53 expression plasmid into a highly pigmented melanoma cell line, overexpression of wt p53 suppressed the pigmentation of the melanoma cells. The loss of pigmentation was associated with the loss of endogenous
tyrosinase
expression at the activity and mRNA levels. In order to determine whether the p53 repression of tyrosinase mRNA involved modulation of
tyrosinase
promoter activity, transient transfection approaches involving p53 expression plasmid and construct containing chloramphenicol acetyl transferase (CAT) reporter gene linked to 270 bp tissue-specific
tyrosinase
promoter have been used. p53 specifically repressed CAT gene expression from the
tyrosinase
promoter and not from the
Rous sarcoma
virus promoter. These data suggest that in human melanoma p53 down-regulates the tissue-specific expression of
tyrosinase
gene and subsequent melanin synthesis.
...
PMID:Tumor suppressor p53 down-regulates tissue-specific expression of tyrosinase gene in human melanoma cell lines. 885 71